1Yun-Lin Wu~1 Bo Sun~1 Xue-Jun Zhang~2 Sheng-Nian Wang~2 Heng-Yi He~2 Min-Min Qiao~1 Jie Zhong~1 Jia-Yu Xu~1 1 Department of Gastroenterology,Ruijin Hospital,Shanghai Second Medical University,Shanghai 200025,China2 Institude of Biochemistry and Cell Biology,Shanghai Institues for Biological Sciences,Chinese Academy of Sciences.Shanghai 200025,China.Growth inhibition and apoptosis induction Sulindac on Human gastric cancer cells[J].World Journal of Gastroenterology,2001,7(6):796-800. 被引量：64
2Vane J, Botting R. Mechanism of action of anti-inflammatory drugs. Int J Tissue React 1998; 20:3-15.
3Sung JJ, Leung WK, Go MY, To KF, Cheng AS, Ng EK, ChanFK. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 2000; 157:729-735.
4Leung WK, To KF, Ng YP, Lee TL, Lau JY, Chan FK, Ng EK,Chung SC, Sung JJ. Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer.Br J Cancer 2001; 84:335-339.
5Pairet M, Engelhardt G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundam Clin Pharmacol 1996; 10:1-15.
6Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999; 18:7908-7916.
7Sawaoka H, Kawano S, Tsuji S, Tsujii M, Gunawan ES, Takei Y, Nagano K, Hori M. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 1998; 274(6 Pt 1): G1061-1067.
8Charalambous D, O'Brien PE. Inhibition of colon cancer precursors in the rat by sulindac sulphone is not dependent on inhibition of prostaglandin synthesis. J Gastroenterol Hepatol 1996; 11:307-310.
9Elder DJ, Halton DE, Hague A, Paraskeva C. Induction of apoptotic cell death in human colorectal carcinoma cell lines bya cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.Clin Cancer Res 1997; 3:1679-1683.
10Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI, Rigas B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 1996; 52:237-245.
2Birner P, Schindl M,Oberhuber G,et al. Overexpression of hypoxia-inducible factor 1 alpha is associated with an unfavorable progno-sis in lymph node - positive breast cancer [ J]. Clin Cancer Res.2002,8(6) :1831 -1837..
3Weidner N, Folkman J, Pozza F, et al . Tumor angiogenesis: anew significant and independent prognostic factor in early - stagebreast carcinoma [J]. J Nat Cancer Ins,1992,84(7) : 1875 -1887.
4Krysan K,Heckamp KL,Sharma S,et al. The potential and rationa-le for COX - 2 inhibitors in lung canner [ J]. Anticancer AgentsMed Chem,2006,6 (3) :209 -220.
5Arun B,Goss P. The role of COX - 2 inhibition in breast cancertreatment and prevention [ J]. Semin Oncol,2004,31 (2 SuppI7):22-29.
6Tanaka F,Otake Y,Yanagihara K,et al. Evaluation of angiogene-sis in non - small cell ling cancer: comparison between anti -CD34 anti - body and anti - CD105 antibody [ J]. Clin cancerRes,2001,7(11):3410 -3415.
7Fonsatti E, Maio M. Highlights on endoglin( CD105) : from basicfindings towards clinical applications in human cancer [ J]. JTransl Med,2004,2(1) :18.
8Minhajat R, Mori D, Yamasaki F,et al. Organ - specific endoglin(CD105) expression in the angiogenesis of human cancers [ J].Pathol lnt,2006,56(12) :717 -723.
